Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GlucoLight promises ICU (intensive care unit) noninvasive continuous glucose monitor

This article was originally published in Clinica

Executive Summary

US company GlucoLight is developing a noninvasive, continuous blood glucose monitor for use in the intensive care unit (ICU), which it says can generate blood glucose readings every 30 seconds. The firm believes that the device, called Sentris-100, could be particularly useful in postoperative patients, who require intensive monitoring and control of blood glucose levels, and that it can help save hospital time and money, and reduce patient morbidity and mortality.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048531

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel